<DOC>
	<DOC>NCT00807248</DOC>
	<brief_summary>To compare the efficacy of escitalopram fixed dose 20 mg/day in combination with fixed doses of gaboxadol (5 and 10 mg/day) versus escitalopram fixed dose 20 mg/day after 8 weeks of treatment in patients with Major Depressive Disorder</brief_summary>
	<brief_title>Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder</brief_title>
	<detailed_description>Subjects participating in this study will be respectively randomised (1:2:2:2) to receive either: - placebo or - escitalopram 20 mg/day or - escitalopram 20 mg/day in combination with gaboxadol 5 mg/day or - escitalopram 20 mg/day in combination with gaboxadol 10 mg/day</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Clinical Diagnosis of MDD according to DSMIVTR criteria: With reported duration of the current major depressive episode of at least 3 months With MADRS total score of at least 30 The patient has 1 or more of the following: Any current psychiatric disorder other than MDD as defined in the DSMIVTR Current or past history of: manic or hypomanic episode, schizophrenia, or any other psychotic disorder, including major depression with psychotic features, mental retardation, organic mental disorders, or mental disorders due to a general medical condition as defined in the DSMIVTR Any substance disorder (except nicotine and caffeine) within the previous 6 months as defined in the DSMIVTR Presence or history of a clinically significant neurological disorder (including epilepsy) Neurodegenerative disorder (Alzheimer disease, Parkinson disease, multiple sclerosis, Huntington disease, etc) Any Axis II disorder that might compromise the study Previous use of hallucinogenic drug The patient has a significant risk of suicide according to the investigator's opinion, or has a score &gt;=5 on item 10 (suicidal thoughts) of the MADRS, or has made a suicide attempt in the previous 12 months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>